TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Qi C et al. | Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine. | 2012 | J. Sci. Food Agric. | pmid:22101976 |
| Teichert SA and Akoh CC | Modifications of stearidonic acid soybean oil by enzymatic acidolysis for the production of human milk fat analogues. | 2011 | J. Agric. Food Chem. | pmid:22097918 |
| Witzleb R et al. | Dissolution of solid lipid extrudates in biorelevant media. | 2012 | Int J Pharm | pmid:22044538 |
| Rago G et al. | CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells. | 2011 | Biomed Opt Express | pmid:21991541 |
| Lopes R et al. | Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. | 2012 | Eur J Pharm Sci | pmid:21983568 |
| Sargsyan E et al. | UPR in palmitate-treated pancreatic beta-cells is not affected by altering oxidation of the fatty acid. | 2011 | Nutr Metab (Lond) | pmid:21978671 |
| Gabert L et al. | 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1,1,1-13C3]tripalmitin and [1,1,1-13C3]triolein. | 2011 | Rapid Commun. Mass Spectrom. | pmid:21913246 |
| Huang Y et al. | Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. | 2011 | J. Biol. Chem. | pmid:21878620 |
| Soll RF et al. | Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. | 1990 | Pediatrics | pmid:2187176 |
| Kuo YC and Chung CY | Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir. | 2011 | Colloids Surf B Biointerfaces | pmid:21865017 |